The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Novartis (Inst)
Concomitant infections in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study.
 
Kyle T. Enriquez
No Relationships to Disclose
 
Gowri Satyanarayana
No Relationships to Disclose
 
Maheen Abidi
Research Funding - Merck
 
Shailesh M Advani
No Relationships to Disclose
 
Pamela Egan
No Relationships to Disclose
 
Arielle Elkrief
No Relationships to Disclose
 
Benjamin French
No Relationships to Disclose
 
Christopher Ryan Friese
Consulting or Advisory Role - Lilly; RTI Health Solutions
Research Funding - Merck (Inst); NCCN/Pfizer (Inst)
Other Relationship - Patient-Centered Outcomes Research Institute (PCORI)
 
Clara Hwang
Stock and Other Ownership Interests - Johnson & Johnson/Janssen (I)
Consulting or Advisory Role - Genzyme
Research Funding - AstraZeneca (Inst); Bausch Health (Inst); Bayer (Inst); Genentech (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Merck
 
Hina Khan
No Relationships to Disclose
 
Gary H. Lyman
Consulting or Advisory Role - BeyondSpring Pharmaceuticals; G1 Therapeutics; Samsung Bioepis; Sandoz-Novartis; Teva
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Bayer
 
Rana R. McKay
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Dendreon; Exelixis; Janssen; Merck; Novartis; Pfizer; Sanofi; Tempus; Vividion Therapeutics
Research Funding - Bayer (Inst); Pfizer (Inst); Tempus (Inst)
 
Gayathri Nagaraj
No Relationships to Disclose
 
Matthew Puc
No Relationships to Disclose
 
Elizabeth M Robilotti
No Relationships to Disclose
 
Shilpa Gupta
Stock and Other Ownership Interests - Nektar
Honoraria - AstraZeneca; Bristol-Myers Squibb; Exelixis; Merck Sharp & Dohme; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Exelixis; Janssen Oncology
Research Funding - Bristol-Myers Squibb; Merck; Pfizer; Seagen
 
Dimpy P Shah
No Relationships to Disclose
 
Trisha Michel Wise-Draper
Stock and Other Ownership Interests - High Enroll
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - Exicure; Rakuten Medical; Shattuck Labs
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Caris Life Sciences; GlaxoSmithKline; GlaxoSmithKline; Merck
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; bexion; Bristol-Myers Squibb; Caris Life Sciences; Lilly; Merck; Tesaro
 
Peter Paul Yu
Stock and Other Ownership Interests - Amazon; Apple; Contrafect; Google; Microsoft
 
Dimitrios Farmakiotis
Research Funding - Astellas Pharma (Inst); Merck (Inst); Viracor Eurofins (Inst)